Abstract
Sarcopenia and osteopenia are two common components of the frailty syndrome that may share a common underlying mechanism. Since frailty has been associated with increased fat infiltration in muscle and bone, we hypothesized that lamin A/C, a protein of the nuclear envelope that regulates adipose differentiation, could be associated with the pathophysiology of both osteo and sarcopenia in the frailty syndrome. Four-week-old lamin A/C null (Lmna(-/-)), heterozygous (Lmna(+/-)) and wild type (WT) mice were sacrificed and their mid-thigh analyzed for fat infiltration using invasive (histology) and non-invasive (μCT) methods. Lmna(-/-) mice showed a significant increase in inter- (~4-fold) and intra-myofiber (~2.5-fold) fat and marrow fat infiltration (~40-fold), with a significant decrease in muscle volume (-42.8%) and bone volume (-21.8%), as compared with WT controls. Furthermore, fat infiltration happened concomitantly with a significant decline in muscle and bone strength in Lmna(-/-) mice. From a mechanistic approach, high levels of pro-adipogenic factors PPARγ and C/EBPα were associated with a reduction in myogenic and osteogenic factors from the Wnt-10b/β-catenin signalling pathway in Lmna(-/-) mice. In conclusion, lamin A/C could constitute the determinant factor in the pathogenesis and potential treatment of both sarcopenia and osteopenia, which are commonly observed in the frailty syndrome.
Original language | English |
---|---|
Pages (from-to) | 552-559 |
Number of pages | 8 |
Journal | Mechanisms of Ageing and Development |
Volume | 132 |
Issue number | 11-12 |
DOIs | |
Publication status | Published - 11 Oct 2011 |
Externally published | Yes |
Keywords
- Adipocytes
- Adipogenesis
- Aged
- Aging
- Animals
- Bone Diseases, Metabolic
- Bone and Bones
- Disease Models, Animal
- Frail Elderly
- Humans
- Lamin Type A
- Mice
- Mice, 129 Strain
- Mice, Inbred C57BL
- Mice, Knockout
- Muscle Development
- Muscle, Skeletal
- Osteogenesis
- PPAR gamma
- Sarcopenia
- Signal Transduction
- Journal Article
- Research Support, Non-U.S. Gov't